Literature DB >> 21031083

An Illustrative Case of Neurofibromatosis Type 1 and NF1 Microdeletion.

L A Praxedes1, F M Pereira, J F Mazzeu, S S Costa, D R Bertola, C A Kim, A M Vianna-Morgante, P A Otto.   

Abstract

We report on a patient with NF1 microdeletion and clinical manifestations that fulfill the diagnostic criteria for neurofibromatosis type 1 but also presenting features reminiscent of Proteus syndrome.

Entities:  

Year:  2010        PMID: 21031083      PMCID: PMC2957849          DOI: 10.1159/000319976

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  12 in total

1.  Proteus syndrome and somatic mosaicism of the chromosome 16.

Authors:  M T Cardoso; T Bunte de Carvalho; L A Casulari; I Ferrari
Journal:  Panminerva Med       Date:  2003-12       Impact factor: 5.197

Review 2.  The challenges of Proteus syndrome: diagnosis and management.

Authors:  Leslie Biesecker
Journal:  Eur J Hum Genet       Date:  2006-08-02       Impact factor: 4.246

3.  Misdiagnosis of neurofibromatosis type 1 as Proteus syndrome.

Authors:  L G Biesecker; M M Cohen
Journal:  Panminerva Med       Date:  2005-09       Impact factor: 5.197

4.  Further diagnostic thoughts about the Elephant Man.

Authors:  M M Cohen
Journal:  Am J Med Genet       Date:  1988-04

5.  NF1 microdeletion breakpoints are clustered at flanking repetitive sequences.

Authors:  M O Dorschner; V P Sybert; M Weaver; B A Pletcher; K Stephens
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

6.  Elevated risk for MPNST in NF1 microdeletion patients.

Authors:  T De Raedt; H Brems; P Wolkenstein; D Vidaud; S Pilotti; F Perrone; V Mautner; S Frahm; R Sciot; E Legius
Journal:  Am J Hum Genet       Date:  2003-03-26       Impact factor: 11.025

Review 7.  PTEN hamartoma tumor syndromes.

Authors:  Gideon M Blumenthal; Phillip A Dennis
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

8.  Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay.

Authors:  M Upadhyaya; M Ruggieri; J Maynard; M Osborn; C Hartog; S Mudd; M Penttinen; I Cordeiro; M Ponder; B A Ponder; M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1998-05       Impact factor: 4.132

Review 9.  The Neurofibromatoses. Part 1: NF1.

Authors:  Christine Lu-Emerson; Scott R Plotkin
Journal:  Rev Neurol Dis       Date:  2009

10.  Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.

Authors:  Lan Kluwe; Reiner Siebert; Stefan Gesk; Reinhard E Friedrich; Sigrid Tinschert; Hildegard Kehrer-Sawatzki; Victor-F Mautner
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  3 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

2.  Screening for mutation site on the type I neurofibromatosis gene in a family.

Authors:  Ming Lv; Wenhua Zhao; Lin Yan; Liang Chen; Kai Cui; Jie Gao; Fachang Yu; Sheng Li
Journal:  Childs Nerv Syst       Date:  2011-12-30       Impact factor: 1.475

3.  Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene.

Authors:  Alessandro Stella; Patrizia Lastella; Luigi Viggiano; Rosanna Bagnulo; Nicoletta Resta
Journal:  Hum Mutat       Date:  2022-06-28       Impact factor: 4.700

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.